CytoDyn to Hold Webcast to Provide a Quarterly Company Update

Rhea-AI Summary

CytoDyn Inc. (OTCQB: CYDY) announced an investment community webcast scheduled for September 28, 2022, at 1:00 pm PT / 4:00 pm ET. The event will feature Board Chair Tanya Urbach, President Cyrus Arman, CFO Antonio Migliarese, and CMO Scott Kelly, who will provide a quarterly update on the company's developments, particularly regarding leronlimab, a CCR5 antagonist. Questions for the webcast can be submitted until Noon PT on September 26, 2022. A replay will be available after the event until October 28, 2022.

Positive

• Scheduled quarterly update webcast indicates transparency and engagement with investors.
• Leadership presence may boost investor confidence and interest in leronlimab developments.

Negative

• Timing of the event might coincide with investor skepticism if recent results were unsatisfactory.

News Market Reaction – CYDY

+2.56%

+2.56% Session move

In the trading session that priced this news, CYDY gained 2.56%, reflecting a moderate positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

VANCOUVER, Washington, Sept. 19, 2022 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTCQB: CYDY) ("CytoDyn" or the "Company"), a biotechnology company developing leronlimab, a CCR5 antagonist with the potential for multiple therapeutic indications, announced today that Tanya Urbach, Board Chair, Cyrus Arman, President, Antonio Migliarese, Chief Financial Officer, and Scott Kelly, Chief Medical Officer and Head of Business Development, will host an investment community webcast to provide a quarterly Company update on Wednesday, September 28, 2022.

Following the update, questions submitted prior to the webcast as directed below will be addressed to the extent appropriate.

Date:	Wednesday, September 28, 2022
Time:	1:00 pm PT / 4:00 pm ET
Access:	https://event.choruscall.com/mediaframe/webcast.html?webcastid=dfBGdCbQ
Questions:	Submit questions prior to the webcast to ir@cytodyn.com not later than Noon PT, Monday, September 26, 2022

This is a livestream presentation. Participants are encouraged to login early prior to the start of the event. The replay will be available approximately 60 minutes after the conclusion of the webcast and can be accessed via the above link until October 28, 2022.

CONTACTS
Investors:
Cristina De Leon
Office: 360.980.8524
ir@cytodyn.com

Media:
Dan Zacchei / Joe Germani
Longacre Square Partners
dzacchei@longacresquare.com / jgermani@longacresquare.com

FAQ

When is the CytoDyn investment community webcast?

The CytoDyn investment community webcast is scheduled for September 28, 2022, at 1:00 pm PT / 4:00 pm ET.

Who will present at the CytoDyn webcast?

The presenters at the CytoDyn webcast will include Board Chair Tanya Urbach, President Cyrus Arman, CFO Antonio Migliarese, and CMO Scott Kelly.

How can I submit questions for the CytoDyn webcast?

Questions can be submitted to ir@cytodyn.com until Noon PT on September 26, 2022.

How can I access the CytoDyn webcast replay?

The replay of the CytoDyn webcast will be available approximately 60 minutes after the event and can be accessed until October 28, 2022, via the provided webcast link.